CFO Bhavana Agrawal resigns, moves to regional role at AstraZeneca Group

Cfo ResignedKmp ResignedManagement Changes View source PDF

ASTRAZEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-0.4%1-day move

₹8050.00

prior close

—

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

————-0.4-2.1-0.5+0.7+0.4—————

Up moveDown movePending

AI summary

Ms. Bhavana Agrawal, Executive Director and CFO of AstraZeneca Pharma India, has resigned as CFO effective August 31, 2026, to take up a regional role within the AstraZeneca Group. She continues as Executive Director. Resignation cited as internal group transition, disclosed under SEBI LODR. She holds no shares in the company.

Likely market impact

CFO transition within parent group; routine internal move. Watch for successor announcement. No governance concerns.